Differential Expression of Glut 1 mRNA and Protein Levels Correlates with Increased Sensitivity to the Glyco-Conjugated Nitric Oxide Donor (2-glu-SNAP) in Different Tumor Cell Types

References

• Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61 (6): 866–879.
   PubMed Web of Science ®Google Scholar
• Nguyen BL, Saitoh M, Ware JA. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 1991; 261(4 Pt 2):H1043-H1052.
   Google Scholar
• Salvemini D, Currie MG, Mollace V. Nitric oxide-mediat-ed cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators. J Clin Invest 1996; 97 (11): 2562–2568.
   PubMed Web of Science ®Google Scholar
• Hibbs JB, Jr., Taintor RR, Vavrin Z. Macrophage cyto-toxicity: role for L-arginine deiminase and imino nitrogen oxi-dation to nitrite. Science 1987; 235 (4787): 473–476.
   PubMed Web of Science ®Google Scholar
• Ignarro LJ, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61 (6): 866–879.
   PubMed Web of Science ®Google Scholar
• Hibbs JB, Jr., Taintor RR, Vavrin Z. Macrophage cyto-toxicity: role for L-arginine deiminase and imino nitrogen oxi-dation to nitrite. Science 1987; 235 (4787): 473–476.
   PubMed Web of Science ®Google Scholar
• Crow JP, Beckman JS. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr Top Microbiol Immunol 1995; 196: 57–73.
   PubMedGoogle Scholar
• Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by perox-ynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87 (4): 1620–1624.
   PubMed Web of Science ®Google Scholar
• Liu J, Li C, Qu W, Leslie E, Bonifant CL, Buzard GS, et al. Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulation. Mol Cancer Ther 2004; 3 (6): 709–714.
   PubMed Web of Science ®Google Scholar
• Azizzadeh B, Yip HT, Blackwell KE, Horvath S, Calcaterra TC, Buga GM, et al. Nitric oxide improves cisplatin cytotoxicity in head and neck squamous cell carcinoma. Laryngoscope 2001; 111(11 Pt 1):1896-1900.
   PubMed Web of Science ®Google Scholar
• Kurimoto M, Endo S, Hirashima Y, Hamada H, Ogiichi T, Takaku A. Growth inhibition and radiosensitization of cul-tured glioma cells by nitric oxide generating agents. J Neurooncol 1999; 42 (1): 35–44.
   PubMed Web of Science ®Google Scholar
• Cantuaria G, Magalhaes A, Angioli R, Mendez L, Mirhashemi R, Wang J, et al. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma. Cancer 2000; 88 (2): 381–388.
   PubMed Web of Science ®Google Scholar
• Hawkins RA, Hoh C, Dahlbom M, Choi Y, Glaspy J, Tse N, et al. PET cancer evaluations with FDG. J Nucl Med 1991; 32 (8): 1555–1558.
   PubMed Web of Science ®Google Scholar
• Liu H, Hu YP, Savaraj N, Priebe W, Lampidis TJ. Hypersensitization of tumor cells to glycolytic inhibitors. Biochemistry 2001; 40 (18): 5542–5547.
   PubMed Web of Science ®Google Scholar
• Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S. Molecular biology of mammalian glucose transporters. Diabetes Care 1990; 13 (3): 198–208.
   PubMed Web of Science ®Google Scholar
• Boado RJ, Pardridge WM. Measurement of blood-brain barrier GLUT1 glucose transporter and actin mRNA by a quantitative polymerase chain reaction assay. J Neurochem 1994; 62 (6): 2085–2090.
   PubMed Web of Science ®Google Scholar
• Stein CH. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase Cl arrest in vitro. J Cell Physiol 1979; 99 (1): 43–54.
   PubMed Web of Science ®Google Scholar
• Cantuaria G, Magalhaes A, Angioli R, Mendez L, Mirhashemi R, Wang J, Wang P, Penalver M, Averette H, Braunschweiger P. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma. Cancer 2000; 88 (2): 381–388.
   PubMed Web of Science ®Google Scholar
• Braunschweiger PG, Basrur VS, Cameron D, Sharpe L, Santos PO, Perras JP, et al. Modulation of cisPlatin cytotox-icity by interleukin-1 alpha and resident tumor macrophages. Biotherapy 1997; 10 (2): 129-137.
   PubMedGoogle Scholar
• Chakrabarti R, Jung CY, Lee TP, Liu H, Mookerjee BK. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J Immunol 1994; 152 (6): 2660–2668.
   PubMed Web of Science ®Google Scholar
• Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002; 32 (6): 1372–1379.
   PubMed Web of Science ®Google Scholar
• Oriuchi N, Higuchi T, Ishikita T, Miyakubo M, Hanaoka H, Iida Y, Endo K. Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci 2006; 97 (12): 1291–1297.
   PubMed Web of Science ®Google Scholar
• Wink DA, Hanbauer I, Grisham MB, Laval F, Nims RW, Laval J, et al. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr Top Cell Regul 1996; 34: 159–187.
   PubMedGoogle Scholar
• Nakajima-Iijima S, Hamada H, Reddy P, Kakunaga T. Molecular structure of the human cytoplasmic beta-actin gene: interspecies homology of sequences in the introns. Proc Natl Acad Sci U S A 1985; 82 (18): 6133–6137.
   PubMed Web of Science ®Google Scholar
• Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, et al. Sequence and structure of a human glu-cose transporter. Science 1985; 229 (4717): 941–945.
   PubMed Web of Science ®Google Scholar
• Muller PY, Janovjak H, Miserez AR, Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 2002; 32 (6): 1372–1379.
   PubMed Web of Science ®Google Scholar